New Director at the Magnetic Resonance Research Center
We are delighted to welcome Dr. Evgenii Kovrigin as the new Director of the Magnetic Resonance Research Center at Notre Dame.
News » Archives » 2018
New study reveals surprising effects of mutations in proteins
Predicting how mutations in proteins alter their ability to function is critical to understanding what drives health and disease in humans. A new study in Structure, Cell Press by scientists at the University of Notre Dame and their colleagues demonstrates how a minor mutation can have far-reaching effects on a protein, playing a role in the onset of different diseases.
Notre Dame's Warren Center for Drug Discovery collaborates with Perlara on screening platform for glycogen storage diseases
Perlara, a rare diseases drug discovery company based in the San Francisco Bay area, recently announced a collaboration called PerlQuest with the University of Notre Dame’s Warren Family Research Center for Drug Discovery and Development.
Study uncovers new hurdle for developing immunotherapies
The body’s immune system is a valiant weapon against disease, and harnessing its power through a technique called immunotherapy is at the forefront of current research to treat cancer and other diseases. That’s why an unexpected finding by Notre Dame researchers and their collaborators, related to the way two distinctively different peptide antigens react with one T-cell receptor, tosses a new wrench into the process of building better molecules to develop immunotherapies.
Notre Dame hosts 5th annual ND-Purdue Symposium on Soft Matter and Polymers
All are invited to attend the annual ND-Purdue Symposium on Soft Matter and Polymers. Hosted by the University of Notre Dame and Purdue University, the event will take place at Notre Dame’s McCourtney Hall on Saturday, October 6 from 8:15 a.m. to 5:45 p.m. EDT.
Notre Dame researchers to tackle autism, preeclampsia and more through new funding
Each year, grants from the Discovery Fund are awarded to researchers who propose novel technologies and diagnostics that can improve human and environmental health.
University of Notre Dame to host Indiana CTSI retreat
Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.
Dovichi receives first College of Science Research Award
Norman Dovichi, the Grace-Rupley Professor of Chemistry and Biochemistry, is the recipient of the inaugural College of Science Research Award.
Biophysicist awarded $1.1 million NIH grant to study role of protein dynamics in antibiotic resistance
The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe. Results from the research of Jeff W. Peng, associate professor of chemistry and biochemistry, could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.
Notre Dame graduate student receives first prize at IU Simon Cancer Center’s annual research day
Chen Dai, University of Notre Dame graduate student of chemistry and biochemistry, was recognized at the Indiana University (IU) Simon Cancer Center’s annual Cancer Research Day. Dai received first prize for his poster presentation in the basic science – graduate student category.
Notre Dame startup Structured Immunity and Medigene announce collaboration aimed at improving T cell receptor development
Structured Immunity, a Notre Dame startup and biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins, and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration where Structured Immunity will provide structural immunology expertise in support of Medigene’s TCR discovery activities.
Baker honored by the American Cancer Society’s Coaches vs. Cancer program
Brian Baker, Rev. John A. Zahm Professor, has received the Innovation Award from the American Cancer Society’s (ACS) local Coaches vs. Cancer program. The Innovation Award is described as being given to “an individual who demonstrates an innovative approach to treating or caring for cancer patients and their loved ones.”
Growth in Notre Dame research and scholarship funding continues
Notre Dame continued the steady expansion and growth of its research, scholarship and creative endeavor programs during the most recent fiscal year, recording $141.6 million in research funding. The amount is part of a trend that has led to a 75 percent increase in external research funding awarded to the University compared to 10 years ago.
NDnano announces 2018 Seed Grant Program recipients
Nine faculty members from the College of Science and College of Engineering have been awarded four grants through the Center for Nano Science and Technology (NDnano) Seed Grant Program.
Notre Dame Hosts 25th Biennial Conference on Chemical Education
Beginning July 29, 2018, Notre Dame will host the 25th Biennial Conference on Chemical Education (BCCE). BCCE is a national meeting designed for college chemistry faculty, graduate students, secondary school chemistry teachers, and middle and elementary school science teachers to share ideas and best practices for chemical education.
Kamat honored in tribute issue of Journal of Physical Chemistry
Prashant Kamat, Rev. John A. Zahm Professor, well known for his contributions to the field of photoelectrochemistry and renewable energy research was honored with a tribute issue to him in one of the four journals of The Journal of Physical Chemistry, published by the American Chemical Society.
Community research collaboration creates better system for treating trauma patients
Trauma, or any kind of severe physical injury, continues to be today’s leading cause of death for people 46 and younger in the United States. In 2007, Dr. Scott Thomas and Dr. Mark Walsh of Memorial Hospital in South Bend were looking for a better way to treat trauma patients who arrived in the emergency room (ER) with excessive bleeding. Their search eventually led to a translational research collaboration with the W. M. Keck Center for Transgene Research at the University of Notre Dame and the development of a new method for treating trauma patients.
Inaugural Woodward Family Endowment for Excellence in NDnano Undergraduate Research awarded
Notre Dame student Margo Waters has received the first Woodward Family Endowment for Excellence in NDnano Undergraduate Research.
New Hope for the Treatment of Diabetic Foot Ulcers
In America, more than a million people suffer from diabetic foot ulcers.
In Latin, SalvePeds means “saving feet.”
And in SalvePeds, a new IDEA Center startup managed and marketed by a team of graduate students at the University of Notre Dame, patients may soon have a more effective option to treat diabetic foot ulcers and prevent some of the 100,000 amputations the condition necessitates every year.
Peng Elected to Experimental NMR Conference Executive Committee
Notre Dame licensee Hsiri Therapeutics enters into agreement for the treatment of mycobacterial diseases
University of Notre Dame licensee Hsiri Therapeutics, Inc., with its corporate headquarters located in Media, PA, has entered into a license agreement with Shionogi & Co., Ltd. regarding a collaborative licensing, research and development program to discover and develop novel therapeutics for non-tuberculous mycobacterial (NTM) diseases and tuberculosis (TB).
Notre Dame researchers collaborate in discovery of potential stroke therapy
A study by researchers at the University of Notre Dame and the University of Missouri at Columbia shows in mice that early administration of a potent compound may increase the window of time in which some stroke patients can receive tPA, a therapeutic that dissolves blood clots.
New molecules created at Notre Dame to reduce cost, environmental impact of mining precious metals
Researchers at the University of Notre Dame have invented a new class of molecules that can be used to simplify the process used for capturing precious metals including gold, platinum, and palladium.
Senior Science students honored at Dean's Awards Luncheon
On Friday, May 18, 2018, more than 50 seniors were honored during The Dean’s Awards luncheon held in the Jordan Hall of Science Galleria.
The Center for Stem Cells and Regenerative Medicine announces the recipients of the 2018 Summer Undergraduate Research Fellowships
Through the generosity of several donors, the Center for Stem Cells and Regenerative Medicine is able to provide summer research fellowships to six outstanding Notre Dame undergraduates this summer.
Clark and Huber Receive 2018 Joyce Awards
Patricia Clark, Rev. John Cardinal O’Hara C.S.C. Professor of Biochemistry, and Paul Huber, Professor of Chemistry & Biochemistry, have been selected as recipients of the 2018 Rev. Edmund P. Joyce C.S.C. Award for Excellence in Undergraduate Teaching.
Andrew Grose named 2018 valedictorian; Harisa Spahić selected as salutatorian
Andrew Grose, who will earn a bachelor of science degree in preprofessional studies with a major in Spanish, has been named valedictorian of the 2018 Notre Dame graduating class. Harisa Spahić, a biochemistry major with minors in anthropology and science, technology and values, is the salutatorian.
Integrated Imaging Facility announces best imaging publications
The Notre Dame Integrated Imaging Facility (NDIIF) is pleased to announce two awards for best imaging publications for calendar year 2017.
Survival strategy: How one enzyme helps bacteria recover from exposure to antibiotics
Researchers at the University of Notre Dame focused on an enzyme in gram-negative bacterium Pseudomonas aeruginosa, a pathogen that causes pneumonia and sepsis.
Notre Dame researchers developing renewable energy approach for producing ammonia
Researchers at Notre Dame are developing a renewable energy approach for synthesizing ammonia, an essential component of fertilizers that support the world’s food production needs. The Haber-Bosch process developed in the early 1900s for producing ammonia relies on non-renewable fossil fuels and has limited applications for only large, centralized chemical plants.